MiRNA Fingerprint Identified in Platelet FormationMarch 17, 2006COLUMBUS, Ohio - Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets - blood cells critical to the body's ability to form clots following an injury. They also say some of these same miRNAs, when acting abnormally, may contribute to certain forms of leukemia. "Basically, we found that a specific set of miRNA genes are turned off in normal platelet development, but turned on in certain platelet-related leukemia cells," says lead author Dr. Ramiro Garzon, a clinical instructor in The Ohio State University College of Medicine. The study is published online in the Proceedings of the National Academy of Sciences.
MiRNA has only recently been acknowledged as an important force in biology. For decades, scientific dogma has held that messenger RNA (mRNA) was responsible for carrying out DNA instructions, or code, for protein production in the cell. Little was known, however, about how cells actually regulated that process. But over the past 10 years, researchers have discovered that miRNA - tiny fragments of RNA typically no more than 20-25 nucleotides in length - also regulates protein synthesis by interfering with mRNA's original instructions. They now know that miRNA helps to regulate many key biological processes, including cell growth, death, development and differentiation. Dr. Carlo Croce, director of Ohio State's Human Cancer Genetics Program, was the first to discover a link between miRNA and cancer. In the current study, Croce, who is also a member of the OSU Comprehensive Cancer Center, along with Garzon and colleagues from the M.D. Anderson Cancer Center, examined miRNA activity in the earliest phases of platelet development. The researchers had previously uncovered substantial evidence linking certain patterns of miRNA to both normal and abnormal blood cell development, especially in diseases like chronic lymphocytic leukemia and lymphoma. Relatively little was known, however, about miRNA functionality in platelet formation. Platelets are created from stem cells in the bone marrow. They evolve through a process called megakaryocytopoiesis, which generates megakaryocytes, or platelet parent cells. The research team used microRNA gene chip analysis to identify miRNA expression in normal stem cells and megakaryoctyes. They also studied miRNA expression patterns in four acute megakaryoblastic leukemia (AMKL) cell lines. They discovered that a set of 17 miRNAs are turned off during normal megakaryocyte differentiation and that 8 of those genes create a molecular signature that clearly defines a megakaryocyte from any other type of cell. "We believe this set of genes may contribute to platelet formation," says Garzon. "We think that when these miRNAs are turned off, it's a signal to other gene targets to get busy with the normal process of development." Garzon says just the opposite happens in AMKL, an unusual form of leukemia more often found in children than adults. In examining four sets of AMKL lines, they found that 10 miRNAs were turned on, again representing a molecular signature for that disease. "Interestingly, half of that number are also members of the miRNA profile in normal platelet cell development - suggesting that this small subset may be most important in understanding how AMKL develops, says Garzon. Researchers believe that more knowledge about miRNA could lead to a new class of targeted therapies that may be helpful in treating leukemia and other diseases. "That day, however, is still a long way off," says Garzon. Grants from the National Cancer Institute, the Leukemia & Lymphoma Society, the Kimmel Foundation and a CLL Research Foundation Grant helped support the study. Additional co-authors from OSU's department of molecular virology, immunology and medical genetics include Flavia Pichiorri, Tizaiana Palumbo, Rodolfo Iuliano, Amelia Cimmino, Rami Aqeilan, Stefano Volinia, Darshna Bhatt, Hansjuerg Alder, Guido Marcucci, George Calin, Chang-Gong Liu and Clara Bloomfield. Michael Andreeff, who also helped with the study, is from the M.D. Anderson Cancer Center. The Ohio State University Medical Center | |||||||||||||||||||||
|
Related MiRNA News Articles Jefferson, Ohio State team find gene signature profile for metastasis A common signature of tiny, specific pieces of non-coding genetic material known as microRNAs (miRNAs) may be directly involved in the spread of cancer to other parts of the body. Yale scientists show that a microRNA can reduce lung cancer growth A small RNA molecule, known as let-7 microRNA (miRNA), substantially reduced cancer growth in multiple mouse models of lung cancer, according to work by researchers at Yale University and Asuragen, Inc., published in the journal Cell Cycle. Less can be more, for plant breeders too Imagine you are a rice breeder and one day within a large field you discover a plant that has just the characteristics you have been looking for. You happily take your special plant to the laboratory where you find out that the spontaneous, beneficial event was due to inactivation of a single gene. Genetic Engineering & Biotechnology News reports on advances in miRNA miRNA research is now one of the most interesting areas in the life science world, reports Genetic Engineering and Biotechnology News (GEN). Making sense of antisense microRNAs Three independent papers in the January 1st issue of G&D report on the discovery of a bidirectionally transcribed microRNA (miRNA) locus in Drosophila. Silencing small but mighty cancer inhibitors Researchers from Johns Hopkins and the University of Pennsylvania have uncovered another reason why one of the most commonly activated proteins in cancer is in fact so dangerous. MicroRNAs may be key to HIV's ability to hide, evade drugs, Jefferson scientists find Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Mechanism for the in-vivo transport of siRNA It all started with flowers: in the nineties of the last century Norwegian researchers discovered that additional copies of a particular gene in petunias inhibited its activity instead of reinforcing it as had been assumed. Bits of 'junk' RNA aid master tumor-suppressor gene Little-known bits of RNA help master tumor-suppressor gene do its job, U-M cancer researchers find. Three micro RNA genes appear to be key partners of protective gene p53; their loss is linked to common type of lung cancer. Ago2 and hematopoiesis Argonaute 2 (Ago2) is unique among its family: It is the only one of the four mammalian Argonaute proteins that exhibits endonuclease "slicer" activity (facilitation of miRNA-guided cleavage of target mRNA). More MiRNA News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||